Nisoldipine coat-core and heart rate response during treatment of hypertension
- PMID: 10344070
Nisoldipine coat-core and heart rate response during treatment of hypertension
Abstract
Nisoldipine coat-core (nisoldipine CC), an extended-release once-daily formulation, is an effective treatment for mild-to-moderate hypertension, providing sustained blood pressure control over the 24-hour dosing interval. Nisoldipine CC is highly vascular selective. It causes neither reflex tachycardia nor symptomatic bradycardia; it lacks significant negative inotropy at therapeutic doses; and it does not affect circadian variation in blood pressure or heart rate. Data suggest that the lack of reflex sympathetic activation in response to the blood pressure-lowering effect of nisoldipine CC is due to the smooth onset of action of nisoldipine CC, causing resetting of the baroflex. The neutral heart rate profile of nisoldipine CC confers potential therapeutic advantages over several other calcium channel blockers, in particular, the short-acting agents, in the treatment of hypertension.
Similar articles
-
Rapid-release and coat-core formulations of nisoldipine in treatment of hypertension, angina, and heart failure.Heart Dis. 1999 Nov-Dec;1(5):279-88. Heart Dis. 1999. PMID: 11720635 Review.
-
Efficacy and tolerability of nisoldipine coat-core formulation in the treatment of essential hypertension: The South African Multicenter ANCHOR Study. Ambulatory Nisoldipine Coat-Core Hypertension Outpatient Response (ANCHOR) Investigators.Am J Hypertens. 1997 Mar;10(3):250-60. doi: 10.1016/s0895-7061(96)00384-6. Am J Hypertens. 1997. PMID: 9056681 Clinical Trial.
-
Nisoldipine CC: efficacy and tolerability in hypertension and ischemic heart disease.Cardiovasc Drugs Ther. 1997 Jan;10 Suppl 3:873-9. doi: 10.1007/BF00051614. Cardiovasc Drugs Ther. 1997. PMID: 9126676 Review.
-
Nisoldipine coat-core. A review of its pharmacodynamic and pharmacokinetic properties and clinical efficacy in the management of ischaemic heart disease.Drugs. 1997 May;53(5):867-84. doi: 10.2165/00003495-199753050-00013. Drugs. 1997. PMID: 9129871 Review.
-
A study to investigate the comparative efficacy and tolerability of nisoldipine coat-core and atenolol in the treatment of mild to moderate hypertension.Br J Clin Pract. 1996 Oct-Nov;50(7):368-72. Br J Clin Pract. 1996. PMID: 9015908 Clinical Trial.
MeSH terms
Substances
LinkOut - more resources
Medical